Dr. Michael Crump Wednesday, April 28, 2021 Dr. Joseph Pater Excellence in Clinical Trials Research Award CCTG is proud to announce that the 2021 Founders Award was presented to Dr. Michael Crump this past weekend at the CCTG Spring Meeting. The Founder's Award is presented annually to an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This award honours an Investigator whose excellence in clinical trials research has provided techniques, information or concepts that will direct the future of the oncology research community and CCTG. 2021 Winner – Dr. Michael Crump Dr. Crump is currently Professor of Medicine at the University of Toronto and attending physician in the Division of Medical Oncology and Hematology at the Princess Margaret Hospital, University Health Network. He has served as Clinical Director of the Autologous Blood and Marrow Transplant Service and was the Lymphoma Site Leader at PMH for longer than anyone cares to remember. In addition to membership on the Breast, Hematology and Investigational New Drug Committee, he had the very good fortune to be serve as co-chair of CCTG’s Hematology Committee with Stephen Couban from 2005 to 2013. Dr. Crump’s current research interests include clinical and translational research in lymphoma, with a focus on improving salvage therapy prior to stem cell transplantation, and development of novel therapies, as well as late effects of treatment. He has been the principal investigator and co-investigator for numerous clinical trials in breast cancer and lymphoma and has authored and co-authored more than 200 peer-reviewed papers and a few book chapters. “I was really very delighted and frankly humbled to be chosen by my colleagues at CCTG for the prestigious CCTG Founder's Award for 2021. I owe a great deal to many people when considering any contributions I have made to the important work of the CCTG over the last twenty five years, but three women in particular stand out. Kathy Pritchard was my main sponsor when I began my involvement with CCTG, pushing me to the front of the room and giving me the opportunity to persuade the Breast Cancer Disease Site Group that trials in autologous stem cell transplant were important to pursue. Elizabeth Eisenhauer provided key early mentorship, helping me gain my research self-confidence and convincing me that hematologist was welcome in the IND programme and drug development meetings, and supporting my clinical trial leadership in leukemia and lymphoma. And Lois Shepherd has provided essential, enduring partnership in virtually everything I have done in the Breast and Hematology Site group, especially during my time as Co-Chair. I have frequently tested her patience, but never doubted her friendship. To everyone else in Kingston and in the clinical investigator community across the country, I am very grateful. It has been my privilege to work with the large group of committed and determined physicians, data coordinators, patient partners, biostatisticians and staff of CCTG for the past 28 years. Working with the CCTG has been the most meaningful and enriching part of my academic career, and to have this recognition from a group of people who I admire and respect is deeply appreciated. I look forward to continuing to work with and learn from you as we develop the next trials that matter to Canadians.“
